ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 27 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $185,000 | -44.6% | 21,402 | -8.6% | 0.00% | – |
| Q4 2021 | $334,000 | -18.7% | 23,406 | +25.0% | 0.00% | – |
| Q3 2021 | $411,000 | +79.5% | 18,727 | +9.2% | 0.00% | – |
| Q2 2021 | $229,000 | +1426.7% | 17,149 | +452.7% | 0.00% | – |
| Q4 2019 | $15,000 | -60.5% | 3,103 | -70.5% | 0.00% | – |
| Q1 2019 | $38,000 | -83.3% | 10,527 | -77.5% | 0.00% | – |
| Q3 2018 | $227,000 | -13.0% | 46,695 | +32.6% | 0.00% | – |
| Q2 2018 | $261,000 | +61.1% | 35,205 | +41.3% | 0.00% | – |
| Q1 2018 | $162,000 | -47.9% | 24,914 | -28.0% | 0.00% | – |
| Q4 2017 | $311,000 | +6.5% | 34,608 | +17.6% | 0.00% | – |
| Q3 2017 | $292,000 | – | 29,434 | +588580.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 5 | -99.9% | 0.00% | – |
| Q3 2016 | $36,000 | +350.0% | 5,005 | +370.8% | 0.00% | – |
| Q2 2016 | $8,000 | -11.1% | 1,063 | -29.1% | 0.00% | – |
| Q1 2016 | $9,000 | – | 1,500 | +1478.9% | 0.00% | – |
| Q4 2015 | $0 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 801,242 | $3,876,000 | 0.50% |
| ARMISTICE CAPITAL, LLC | 624,000 | $3,039,000 | 0.18% |
| Rossmore Private Capital | 15,061 | $73,000 | 0.03% |
| Sterling Investment Advisors, Ltd. | 3,150 | $15,000 | 0.01% |
| Squarepoint Ops LLC | 14,500 | $71,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
| Close Asset Management Ltd | 2,000 | $10,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 16,900 | $82,000 | 0.00% |
| SIMPLEX TRADING, LLC | 547 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 861 | $4,000 | 0.00% |